Lowering Blood Pressure to 120 Benefits Patients with Diabetes
New insights reveal improved cardiovascular outcomes with intensive blood pressure control in diabetes.
Topline
Intensive blood pressure management targeting systolic levels under 120 mm Hg reduces cardiovascular events by 21% in patients with type 2 diabetes, as shown in the BPROAD trial.
Study Details
The BPROAD trial addresses the long-standing debate on optimal blood pressure targets for patients with type 2 diabetes. Cardiovascular risks are higher in t…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.